Value, Affordability, and Decision Making
Efficient decisions about allocating health care budgets require assessment of the effects of health care interventions and the value for money they provide. Decision-making processes leading to funding decisions should be structured and evidence-based.
Projecting Expenditure on Medicines in the NHS: Second Edition
1 January 2014
The Pharmaceutical Price Regulation Scheme (PPRS) 2014 Heads of Agreement, announced on 6 November 2013, outlines the terms of the five-year deal between the pharmaceuctical industry…
Inconsistent Use of Cost-effectiveness Thresholds in NHS Scotland
12 December 2013
This study finds an apparent mismatch in the decision making approaches of the SMC and the NHS Boards. OHE today released a Research Paper on the…
Using MCDA to Assess the Value of Treatments for Rare Diseases
5 December 2013
A pilot study demonstrated the value of involving a range of stakeholders in MCDA for rare disease therapies. According to a study just published by the…
Critique of Research Proposing to Lower NICE’s Cost-per-QALY Threshold to £12,936
2 December 2013
This paper counters recent research that recommended NICE lower its threshold from the current official £20,000-£30,000. Critique of CHE Research Paper 81: Methods for the Estimation…
NICE Decisions: Cost-effectiveness is the Most Significant Predictor
21 November 2013
Using data for 1999-2011, this thorough analysis explores what has most influenced NICE’s decisions and whether this has changed. Established in 1999, the National Institute for…
What Is the Role of Cost-Effectiveness Evidence in US Health Care?
31 July 2013
At an OHE seminar last week, Dr James Chambers of Tufts Medical School examined the role cost-effectiveness evidence plays in health care resource allocation in the…
Exploring the Link Between Health and Wealth in Government Decision Making
16 May 2013
Traditionally, decision makers both within and outside the health sector have thought of the value of health interventions primarily in terms of reduced morbidity or mortality.…
Valuing Orphan Medicines Using Multi-Criteria Decision Analysis
7 May 2013
OHE has just released a research paper that describes an experimental study intended to test whether and how a multi-criteria decision analysis (MCDA) approach can be…
OHE Presents at Two Key Workshops on Use of EQ-5D in HTA Across Asia
27 March 2013
OHE’s Prof Nancy Devlin presented at two key workshops held for researchers and HTA policy makers from across Asia. The workshops were organised by Prof Nan…